Q1 2023 Agios Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Agios' First Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Agios' Chief Financial Officer, Cecilia Jones. Please go ahead.
Thank you, operator. Good morning, everyone, and welcome to Agios first quarter 2023 conference call. You can access slides for today's call by going to the Investors section of our website, agios.com.
On today's call, I am joined our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; and Tsveta Milanova, our Chief Commercial Officer.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |